Cargando…
Acute myocarditis following administration of BNT162b2 vaccine
The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.
Autores principales: | Habib, Mhd Baraa, Hamamyh, Tahseen, Elyas, Ahmed, Altermanini, Mohammed, Elhassan, Mawahib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220234/ https://www.ncbi.nlm.nih.gov/pubmed/34189042 http://dx.doi.org/10.1016/j.idcr.2021.e01197 |
Ejemplares similares
-
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
por: Altermanini, Mohammad, et al.
Publicado: (2023) -
Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose
por: Miqdad, Mohammed A, et al.
Publicado: (2021) -
SIMULTANEOUS ACUTE THROMBOTIC OCCLUSION INVOLVING THREE CORONARY ARTERIES. A UNIQUE ASSOCIATION WITH COVID-19 PNEUMONIA
por: Habib, Mhd Baraa, et al.
Publicado: (2022) -
Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19
por: Bautista García, Javier, et al.
Publicado: (2021) -
Acute myocarditis after administration of BNT162b2 vaccine against COVID-19
por: Cueva-Recalde, Juan F., et al.
Publicado: (2023)